日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A placebo-controlled Phase 2 trial of E6011, anti-human fractalkine monoclonal antibody, in primary biliary cholangitis

一项针对原发性胆汁性胆管炎的安慰剂对照 II 期临床试验,研究了抗人趋化因子单克隆抗体 E6011 的疗效。

Tanaka, Atsushi; Abe, Masanori; Namisaki, Tadashi; Shimoda, Shinji; Zeniya, Mikio; Ido, Akio; Yoshiji, Hitoshi; Ohira, Hiromasa; Harada, Kenichi; Kakuda, Yuko; Umeda, Atsushi; Kamiya, Yuki; Higashine, Yukari; Hojo, Seiichiro; Imai, Toshio; Kawano, Tetsu; Nakanuma, Yasuni; Tsubouchi, Hirohito

Platelet activation through CD62P and the formation of platelet-monocyte complexes are associated with the exacerbation of mucosal inflammation in patients with ulcerative colitis.

血小板通过 CD62P 活化以及血小板-单核细胞复合物的形成与溃疡性结肠炎患者黏膜炎症的加剧有关

Sano Yasuki, Tomiyama Takashi, Yagi Naoto, Ito Yuka, Honzawa Yusuke, Tahara Tomomitsu, Ikeura Tsukasa, Fukui Toshiro, Shimoda Shinji, Naganuma Makoto

Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib

乐伐替尼联合经动脉化疗栓塞治疗早期接受剂量不足的肝细胞癌患者的疗效

Promsorn, Panuwat; Yamaguchi, Takashi; Kosaka, Hisashi; Aoi, Kazunori; Yoshida, Katsunori; Matsushima, Hideyuki; Matsui, Kosuke; Shimoda, Shinji; Kaibori, Masaki; Naganuma, Makoto

Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study

CBP/β-catenin抑制剂PRI-724在丙型和乙型肝炎病毒引起的肝硬化患者中的安全性、耐受性和抗纤维化疗效:一项研究者发起的、开放标签、非随机、多中心、1/2a期研究

Kimura, Kiminori; Kanto, Tatsuya; Shimoda, Shinji; Harada, Kenichi; Kimura, Masamichi; Nishikawa, Koji; Imamura, Jun; Ogawa, Eiichi; Saio, Masanao; Ikura, Yoshihiro; Okusaka, Takuji; Inoue, Kazuaki; Ishikawa, Tetsuya; Ieiri, Ichiro; Kishimoto, Junji; Todaka, Koji; Kamisawa, Terumi

P1088: UPDATED DATA FROM A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN COMBINED WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA

P1088:一项针对晚期经典型霍奇金淋巴瘤患儿的布伦妥昔单抗联合化疗的1/2期研究的最新数据

Ogawa, Eiichi; Nakamuta, Makoto; Koyanagi, Toshimasa; Ooho, Aritsune; Furusyo, Norihiro; Kajiwara, Eiji; Dohmen, Kazufumi; Kawano, Akira; Satoh, Takeaki; Takahashi, Kazuhiro; Azuma, Koichi; Yamashita, Nobuyuki; Yamashita, Naoki; Sugimoto, Rie; Amagase, Hiromasa; Kuniyoshi, Masami; Ichiki, Yasunori; Morita, Chie; Kato, Masaki; Shimoda, Shinji; Nomura, Hideyuki; Hayashi, Jun; Locatelli, F; Luisi, F; Pianovski, M; Salvino, M A; Fagioli, F; Epelman, S; Britto De Abreu Lima, L; Norris, R; Odone Filho, V; Zecca, M; Favre, C; Kobayashi, R; Koga, Y; Sidi, Y; Zhou, X; Bai, X; Campana, F; Leonard, E J; Franklin, A R

Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals

接受直接抗病毒药物治疗的75-84岁慢性丙型肝炎患者发生肝细胞癌的情况

Ogawa, Eiichi; Nomura, Hideyuki; Nakamuta, Makoto; Furusyo, Norihiro; Kajiwara, Eiji; Dohmen, Kazufumi; Kawano, Akira; Ooho, Aritsune; Azuma, Koichi; Takahashi, Kazuhiro; Satoh, Takeaki; Koyanagi, Toshimasa; Ichiki, Yasunori; Kuniyoshi, Masami; Yanagita, Kimihiko; Amagase, Hiromasa; Morita, Chie; Sugimoto, Rie; Kato, Masaki; Shimoda, Shinji; Hayashi, Jun

Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals

对接受直接抗病毒药物治疗后慢性丙型肝炎患者进行肝细胞癌复发的长期评估

Ogawa, Eiichi; Nakamuta, Makoto; Furusyo, Norihiro; Kajiwara, Eiji; Dohmen, Kazufumi; Kawano, Akira; Ooho, Aritsune; Azuma, Koichi; Takahashi, Kazuhiro; Satoh, Takeaki; Koyanagi, Toshimasa; Yamashita, Nobuyuki; Ichiki, Yasunori; Yamashita, Naoki; Kuniyoshi, Masami; Yanagita, Kimihiko; Amagase, Hiromasa; Morita, Chie; Sugimoto, Rie; Kato, Masaki; Shimoda, Shinji; Nomura, Hideyuki; Hayashi, Jun

Evaluation of Enamel Acid Resistance and Whitening Effect of the CAP System

CAP系统牙釉质耐酸性和增白效果评价

Miki, Naoko; Miake, Yasuo; Shimoda, Shinji; Mishima, Hiroyuki

Clinical significance of SARS-CoV-2-specific IgG detection with a rapid antibody kit for COVID-19 patients

快速抗体检测试剂盒检测SARS-CoV-2特异性IgG对COVID-19患者的临床意义

Chong, Yong; Ikematsu, Hideyuki; Tani, Naoki; Arimizu, Yoko; Watanabe, Haruka; Fukamachi, Yukako; Yonekawa, Akiko; Iwasaka, Sho; Nishida, Ruriko; Eriguchi, Yoshihiro; Miyake, Noriko; Shimoda, Shinji; Nagasaki, Yoji; Shimono, Nobuyuki; Akashi, Koichi

Integrated GWAS and mRNA Microarray Analysis Identified IFNG and CD40L as the Central Upstream Regulators in Primary Biliary Cholangitis

整合全基因组关联分析和mRNA微阵列分析鉴定出IFNG和CD40L是原发性胆汁性胆管炎的关键上游调控因子

Ueno, Kazuko; Aiba, Yoshihiro; Hitomi, Yuki; Shimoda, Shinji; Nakamura, Hitomi; Gervais, Olivier; Kawai, Yosuke; Kawashima, Minae; Nishida, Nao; Kohn, Seik-Soon; Kojima, Kaname; Katsushima, Shinji; Naganuma, Atsushi; Sugi, Kazuhiro; Komatsu, Tatsuji; Mannami, Tomohiko; Matsushita, Kouki; Yoshizawa, Kaname; Makita, Fujio; Nikami, Toshiki; Nishimura, Hideo; Kouno, Hiroshi; Kouno, Hirotaka; Ohta, Hajime; Komura, Takuya; Tsuruta, Satoru; Yamauchi, Kazuhiko; Kobata, Tatsuro; Kitasato, Amane; Kuroki, Tamotsu; Abiru, Seigo; Nagaoka, Shinya; Komori, Atsumasa; Yatsuhashi, Hiroshi; Migita, Kiyoshi; Ohira, Hiromasa; Tanaka, Atsushi; Takikawa, Hajime; Nagasaki, Masao; Tokunaga, Katsushi; Nakamura, Minoru